113 related articles for article (PubMed ID: 11375311)
1. LightCycler PCR assay for genotyping codon 634 mutations in the RET protooncogene.
de la Fuente M; Quinteiro C; Dominguez F; Loidi L
Clin Chem; 2001 Jun; 47(6):1131-2. PubMed ID: 11375311
[No Abstract] [Full Text] [Related]
2. The future of mutation detection.
Luft FC
J Mol Med (Berl); 1997 Oct; 75(10):692-3. PubMed ID: 9382992
[No Abstract] [Full Text] [Related]
3. Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma.
Siegelman M; Mohabeer A; Fahey TJ; Tomlinson G; Mayambala C; Jafari S; Noll WW; Thibodeau SN; Dawson DB
Clin Chem; 1997 Mar; 43(3):453-7. PubMed ID: 9068588
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
5. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.
Huang CN; Wu SL; Chang TC; Huang SH; Chang TJ
J Formos Med Assoc; 1998 Aug; 97(8):541-6. PubMed ID: 9747064
[TBL] [Abstract][Full Text] [Related]
6. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.
Blaugrund JE; Johns MM; Eby YJ; Ball DW; Baylin SB; Hruban RH; Sidransky D
Hum Mol Genet; 1994 Oct; 3(10):1895-7. PubMed ID: 7849720
[No Abstract] [Full Text] [Related]
7. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
[TBL] [Abstract][Full Text] [Related]
8. Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B.
Kitamura Y; Scavarda N; Wells SA; Jackson CE; Goodfellow PJ
Hum Mol Genet; 1995 Oct; 4(10):1987-8. PubMed ID: 8595427
[No Abstract] [Full Text] [Related]
9. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
10. Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease.
Fitze G; Schreiber M; Kuhlisch E; Schackert HK; Roesner D
Am J Hum Genet; 1999 Nov; 65(5):1469-73. PubMed ID: 10521317
[No Abstract] [Full Text] [Related]
11. Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.
Frank-Raue K; Höppner W; Frilling A; Kotzerke J; Dralle H; Haase R; Mann K; Seif F; Kirchner R; Rendl J; Deckart HF; Ritter MM; Hampel R; Klempa J; Scholz GH; Raue F
J Clin Endocrinol Metab; 1996 May; 81(5):1780-3. PubMed ID: 8626834
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas.
Shan L; Nakamura M; Nakamura Y; Utsunomiya H; Shou N; Jiang X; Jing X; Yokoi T; Kakudo K
Jpn J Cancer Res; 1998 Sep; 89(9):883-6. PubMed ID: 9818022
[TBL] [Abstract][Full Text] [Related]
13. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.
Komminoth P; Kunz EK; Matias-Guiu X; Hiort O; Christiansen G; Colomer A; Roth J; Heitz PU
Cancer; 1995 Aug; 76(3):479-89. PubMed ID: 8625130
[TBL] [Abstract][Full Text] [Related]
14. A de novo mutation of the RET proto-oncogene in a patient with MEN 2A.
Mulligan LM; Eng C; Healey CS; Ponder MA; Feldman GL; Li P; Jackson CE; Ponder BA
Hum Mol Genet; 1994 Jun; 3(6):1007-8. PubMed ID: 7951212
[No Abstract] [Full Text] [Related]
15. A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.
Tessitore A; Sinisi AA; Pasquali D; Cardone M; Vitale D; Bellastella A; Colantuoni V
J Clin Endocrinol Metab; 1999 Oct; 84(10):3522-7. PubMed ID: 10522989
[TBL] [Abstract][Full Text] [Related]
16. One-step analysis of ten functional haplotype combinations of the basic RET promoter with a LightCycler assay.
Görgens H; Fitze G; Roesner D; Schackert HK
Clin Chem; 2004 Sep; 50(9):1693-5. PubMed ID: 15265820
[No Abstract] [Full Text] [Related]
17. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnosis of multiple type 2 endocrine neoplasia].
Amosenko FA; Pushkash K; Frilling A; Kozlova VN; Liubchenko LN; Kazubskaia TP; Brelysh KE; Gar'kavtseva RF; Kalinin VN
Vestn Ross Akad Med Nauk; 2001; (2):34-7. PubMed ID: 11338505
[TBL] [Abstract][Full Text] [Related]
19. RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.
Kim IJ; Kang HC; Park JH; Ku JL; Lee JS; Kwon HJ; Yoon KA; Heo SC; Yang HY; Cho BY; Kim SY; Oh SK; Youn YK; Park DJ; Lee MS; Lee KW; Park JG
Clin Cancer Res; 2002 Feb; 8(2):457-63. PubMed ID: 11839664
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A
Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
